Evidence map›Paper›PMID 40436893›Full record

ArticleNature communications2025

ACE2 from Pipistrellus abramus bats is a receptor for HKU5 coronaviruses.

Nicholas J Catanzaro, Ziyan Wu, Chengcheng Fan, Victoria Jefferson, Anfal Abdelgadir, Alexandra Schäfer, Boyd L Yount, Pamela J Bjorkman, Ralph Baric, Michael Letko

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Nicholas J Catanzaro *Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Ziyan Wu *Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Chengcheng FanDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0000-0003-4213-5758
Victoria JeffersonPaul G. Allen School for Global Health, Washington State University, Pullman, WA, USA.ORCID http://orcid.org/0000-0003-3056-1813
Anfal AbdelgadirDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Alexandra SchäferDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0002-4760-4923
Boyd L YountDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Pamela J BjorkmanDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0000-0002-2277-3990
Ralph BaricDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0001-6827-8701
Michael LetkoPaul G. Allen School for Global Health, Washington State University, Pullman, WA, USA. michael.letko@wsu.edu.ORCID http://orcid.org/0000-0002-7640-2861

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
Stuctural basis of bNab activityP01AI100148 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI Pamela J Bjorkman · 2013 to 2026
$43.3M
Structure-based design of broadly protective coronavirus vaccinesP01AI167966 · NIAID · UNIVERSITY OF WASHINGTON · PI Ralph S Baric · 2022 to 2026
$15.3M
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responsesP01AI165075 · NIAID · ROCKEFELLER UNIVERSITY · PI RICE, CHARLES M · 2022 to 2023
$10.7M
Infectious Diseases and Microbial Immunology Training ProgramT32AI007025 · NIAID · WASHINGTON STATE UNIVERSITY · PI Thomas H KAWULA, M KARIUKI NJENGA · 1985 to 2026
$7.4M
Functional Viromics of Betacoronavirus EntryR01AI179720 · NIAID · WASHINGTON STATE UNIVERSITY · PI Barbara A. Han, Michael Letko · 2024 to 2026
$1.1M
NIAID NIH HHS 75N93021C00014NIAID NIH HHS P01 AI100148NIAID NIH HHS P01 AI165075NIAID NIH HHS P01 AI167966NIAID NIH HHS R01 AI179720NIAID NIH HHS T32 AI007025U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI167966
6 · The paper itself

Abstract

The merbecovirus subgenus of coronaviruses includes Middle East Respiratory Syndrome Coronavirus (MERS-CoV), a zoonotic pathogen transmitted from dromedary camels to humans that causes severe respiratory disease. Viral discovery efforts uncover hundreds of merbecoviruses in different species across multiple continents, but few are studied under laboratory conditions, leaving basic questions regarding their human threat potential unresolved. Viral entry into host cells is a critical step for transmission between hosts. Here, we develop and apply a scalable approach to assesses novel merbecovirus cell entry across the entire merbecovirus subgenus. Merbecoviruses are sorted into clades based on the receptor-binding domain of the spike glycoprotein. Receptor tropism is clade-specific, with the clade including MERS-CoV using DPP4 and multiple clades using ACE2, including HKU5 bat coronaviruses. Mutational analysis identifies possible structural limitations to HKU5 adaptability and a cryo-EM structure of the HKU5-20s spike trimer reveals only 'down' RBDs.

Indexed as

Angiotensin-Converting Enzyme 2ChiropteraCoronavirusReceptors, VirusAnimalsCryoelectron MicroscopyDipeptidyl Peptidase 4HEK293 CellsHumansMiddle East Respiratory Syndrome CoronavirusPhylogenySpike Glycoprotein, CoronavirusViral TropismVirus InternalizationAngiotensin-Converting Enzyme 2Dipeptidyl Peptidase 4Receptors, VirusSpike Glycoprotein, Coronavirus

Identifiers

PMID40436893
PMCPMC12119886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.